2.4.1.9 Html 85 134 1 false 30 0 false 5 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://cumberlandpharma.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 1001000 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://cumberlandpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) false false R3.htm 1001501 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://cumberlandpharma.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) false false R4.htm 1002000 - Statement - Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited) Sheet http://cumberlandpharma.com/role/CondensedConsolidatedStatementsOfIncomeAndComprehensiveIncomeUnaudited Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited) false false R5.htm 1003000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://cumberlandpharma.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) false false R6.htm 1004000 - Statement - Condensed Consolidated Statement of Equity (Unaudited) Sheet http://cumberlandpharma.com/role/CondensedConsolidatedStatementOfEquityUnaudited Condensed Consolidated Statement of Equity (Unaudited) false false R7.htm 2101100 - Disclosure - Organization and Basis of Presentation Sheet http://cumberlandpharma.com/role/OrganizationAndBasisOfPresentation Organization and Basis of Presentation false false R8.htm 2102100 - Disclosure - Marketable Securities Sheet http://cumberlandpharma.com/role/MarketableSecurities Marketable Securities false false R9.htm 2103100 - Disclosure - Earnings Per Share Sheet http://cumberlandpharma.com/role/EarningsPerShare Earnings Per Share false false R10.htm 2104100 - Disclosure - Revenues Sheet http://cumberlandpharma.com/role/Revenues Revenues false false R11.htm 2105100 - Disclosure - Inventories Sheet http://cumberlandpharma.com/role/Inventories Inventories false false R12.htm 2106100 - Disclosure - Shareholders' Equity and Debt Sheet http://cumberlandpharma.com/role/ShareholdersEquityAndDebt Shareholders' Equity and Debt false false R13.htm 2107100 - Disclosure - Income Taxes Sheet http://cumberlandpharma.com/role/IncomeTaxes Income Taxes false false R14.htm 2108100 - Disclosure - Collaborative Agreements Sheet http://cumberlandpharma.com/role/CollaborativeAgreements Collaborative Agreements false false R15.htm 2109100 - Disclosure - Commitments and Contingencies Sheet http://cumberlandpharma.com/role/CommitmentsAndContingencies Commitments and Contingencies false false R16.htm 2111100 - Disclosure - New Products Sheet http://cumberlandpharma.com/role/NewProducts New Products false false R17.htm 2201201 - Disclosure - Organization and Basis of Presentation (Policies) Sheet http://cumberlandpharma.com/role/OrganizationAndBasisOfPresentationPolicies Organization and Basis of Presentation (Policies) false false R18.htm 2302301 - Disclosure - Marketable Securities (Tables) Sheet http://cumberlandpharma.com/role/MarketableSecuritiesTables Marketable Securities (Tables) false false R19.htm 2303301 - Disclosure - Earnings Per Share (Tables) Sheet http://cumberlandpharma.com/role/EarningsPerShareTables Earnings Per Share (Tables) false false R20.htm 2304301 - Disclosure - Revenues (Tables) Sheet http://cumberlandpharma.com/role/RevenuesTables Revenues (Tables) false false R21.htm 2305301 - Disclosure - Inventories (Tables) Sheet http://cumberlandpharma.com/role/InventoriesTables Inventories (Tables) false false R22.htm 2401402 - Disclosure - Organization and Basis of Presentation Organization (Details) Sheet http://cumberlandpharma.com/role/OrganizationAndBasisOfPresentationOrganizationDetails Organization and Basis of Presentation Organization (Details) false false R23.htm 2402402 - Disclosure - Marketable Securities (Details) Sheet http://cumberlandpharma.com/role/MarketableSecuritiesDetails Marketable Securities (Details) false false R24.htm 2403402 - Disclosure - Earnings Per Share (Details) Sheet http://cumberlandpharma.com/role/EarningsPerShareDetails Earnings Per Share (Details) false false R25.htm 2403403 - Disclosure - Earnings Per Share (Details Textual) Sheet http://cumberlandpharma.com/role/EarningsPerShareDetailsTextual Earnings Per Share (Details Textual) false false R26.htm 2404402 - Disclosure - Revenues (Details) Sheet http://cumberlandpharma.com/role/RevenuesDetails Revenues (Details) false false R27.htm 2404403 - Disclosure - Revenues (Details Textual) Sheet http://cumberlandpharma.com/role/RevenuesDetailsTextual Revenues (Details Textual) false false R28.htm 2405402 - Disclosure - Inventories (Details) Sheet http://cumberlandpharma.com/role/InventoriesDetails Inventories (Details) false false R29.htm 2405403 - Disclosure - Inventories (Details Textual) Sheet http://cumberlandpharma.com/role/InventoriesDetailsTextual Inventories (Details Textual) false false R30.htm 2406401 - Disclosure - Shareholders' Equity and Debt (Shareholders' Equity) (Details) Sheet http://cumberlandpharma.com/role/ShareholdersEquityAndDebtShareholdersEquityDetails Shareholders' Equity and Debt (Details) false false R31.htm 2406402 - Disclosure - Shareholders' Equity and Debt (Debt) (Details) Sheet http://cumberlandpharma.com/role/ShareholdersEquityAndDebtDebtDetails Shareholders' Equity and Debt (Debt) (Details) false false R32.htm 2407401 - Disclosure - Income Taxes (Details Textual) Sheet http://cumberlandpharma.com/role/IncomeTaxesDetailsTextual Income Taxes (Details Textual) false false R33.htm 2411401 - Disclosure - New Products - Narrative (Details) Sheet http://cumberlandpharma.com/role/NewProductsNarrativeDetails New Products - Narrative (Details) false false All Reports Book All Reports Element us-gaap_StockRepurchasedDuringPeriodValue had a mix of decimals attribute values: -5 0. 'Shares' elements on report '2406401 - Disclosure - Shareholders' Equity and Debt (Shareholders' Equity) (Details)' had a mix of different decimal attribute values. Process Flow-Through: 1001000 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Process Flow-Through: Removing column 'Mar. 31, 2014' Process Flow-Through: Removing column 'Dec. 31, 2013' Process Flow-Through: 1001501 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Process Flow-Through: 1002000 - Statement - Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited) Process Flow-Through: 1003000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) cpix-20141231.xml cpix-20141231.xsd cpix-20141231_cal.xml cpix-20141231_def.xml cpix-20141231_lab.xml cpix-20141231_pre.xml true true